ClinicalTrials.govpublic full text
GnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Locally Advanced or Metastatic PDAC
locally advanced pancreatic cancer, metastatic pancreatic cancer, shr-1701, apatinib, gnp, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831212
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.